p53 functions as a cell cycle control protein in osteosarcomas.
Open Access
- 1 November 1990
- journal article
- research article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 10 (11) , 5772-5781
- https://doi.org/10.1128/mcb.10.11.5772
Abstract
Mutations in the p53 gene have been associated with a wide range of human tumors, including osteosarcomas. Although it has been shown that wild-type p53 can block the ability of E1a and ras to cotransform primary rodent cells, it is poorly understood why inactivation of the p53 gene is important for tumor formation. We show that overexpression of the gene encoding wild-type p53 blocks the growth of osteosarcoma cells. The growth arrest was determined to be due to an inability of the transfected cells to progress into S phase. This suggests that the role of the p53 gene as an antioncogene may be in controlling the cell cycle in a fashion analogous to the check-point control genes in Saccharomyces cerevisiae.This publication has 60 references indexed in Scilit:
- Mutations in the p53 gene occur in diverse human tumour typesNature, 1989
- The retinoblastoma protein is phosphorylated during specific phases of the cell cycleCell, 1989
- The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory elementCell, 1989
- Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiationCell, 1989
- The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigenCell, 1989
- Chromosome 17 Deletions and p53 Gene Mutations in Colorectal CarcinomasScience, 1989
- Structural Evidence for the Authenticity of the Human Retinoblastoma GeneScience, 1987
- A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcomaNature, 1986
- T antigen is bound to a host protein in SY40-transformed cellsNature, 1979
- Revertants of Human Cells Transformed by Murine Sarcoma VirusScience, 1976